Tigecycline without crystal habit and method of preparing the same

A tigecycline, crystal-free technology, used in organic chemistry, separation/purification of carboxylic acid amides, etc., can solve problems such as tigecycline that has not yet seen a crystal-free form, and achieve the effect of obvious bacteriostatic activity

Inactive Publication Date: 2009-02-18
SHANGHAI LAIYI BIOMEDICAL RES & DEV CENT +1
View PDF2 Cites 9 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

And so far, there is no report about

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Tigecycline without crystal habit and method of preparing the same
  • Tigecycline without crystal habit and method of preparing the same
  • Tigecycline without crystal habit and method of preparing the same

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0028] Example 1 , the preparation of tigecycline without crystalline form

[0029] Weigh 0.2 g of crude tigecycline (content about 70%), dissolve it completely with 40 ml of water, and then adjust the pH of the solution to 2.0 with 1 mol / L HCl;

[0030] Add 20ml of HP2MG macroporous adsorption resin (Mitsubishi Chemical) to the solution, stir and adsorb at 100rpm for 1 hour, filter to remove the resin, adjust the pH of the adsorption residue to 8.5 with 1mol / L NaOH; then use dichloromethane and acetonitrile 2:1 to form The mixed solvent was extracted twice, 40ml each time, and the extracts were collected and combined;

[0031] The collected extract was concentrated and dried under vacuum at 20°C to obtain 0.08 g of tigecycline powder.

[0032] Use the X-ray powder diffraction method to detect the powder obtained, and the diffraction pattern is as follows figure 2 shown. Depend on figure 2 As can be seen from the results, the diffraction pattern shows a flat curve and ...

Embodiment 2

[0037] Example 2 , the preparation of tigecycline without crystalline form

[0038] Weigh 5.4g of crude tigecycline (content about 70%), dissolve it completely with 800ml of water, and then adjust the pH of the solution to 3.0 with 1mol / L HCl;

[0039] Add 400ml of prepared Amberlite XAD-6 macroporous adsorption resin (Rohm and Haas, USA) to the solution, stir and adsorb at 100rpm for 1 hour, remove the resin by filtration, and adjust the pH of the adsorption raffinate to 8.0 with 1mol / L NaOH; Extract twice with methane, 800ml each time, collect and combine the extracts;

[0040] The collected extract was concentrated and dried under vacuum at 30° C. to obtain 2.3 g of tigecycline powder.

[0041] The obtained powder sample is detected by X-ray powder diffraction method, and the diffraction pattern is as follows image 3 shown. Depend on image 3 As can be seen from the results, the diffraction pattern shows a flat curve and does not show any peak shape, so it can be det...

Embodiment 3

[0043] Example 3 , the preparation of tigecycline without crystalline form

[0044] Weigh 40 g of crude tigecycline (content about 70%), dissolve it completely with 4000 ml of water, and then adjust the pH of the solution to 2.5 with 1 mol / L HCl;

[0045] Add 2000ml of prepared HP2MG macroporous adsorption resin (Mitsubishi Chemical) to the solution, stir and adsorb at 100rpm for 1 hour, filter to remove the resin, and adjust the pH of the adsorption raffinate to 8.3 with 1mol / L NaOH;

[0046] Then extract twice with the mixed solvent that dichloromethane and methanol 3:1 constitute, each 4000ml, collect and combine extract;

[0047] The collected extract was concentrated and dried under vacuum at 15°C to obtain 18.0 g of tigecycline powder.

[0048] Use the X-ray powder diffraction method to detect the powder obtained, and the diffraction pattern is as follows Figure 4 shown. Depend on Figure 4 As can be seen from the results, the diffraction pattern shows a flat curv...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention provides a no-crystalline state tigecycline and a preparation method of the tigecycline. The present invention has obvious bacteriostasis activity.

Description

technical field [0001] The invention belongs to the field of chemical industry and pharmacy, and in particular relates to tigecycline without crystal form and a preparation method thereof. Background technique [0002] Tigecycline (tigecycline), chemical name: (4S, 4aS, 5aR, 12aS)-4,7-bis(dimethylamino)-9-[(tert-butylamino)acetamido]-3,10, 12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide, also known as 9-tert-butylglycerol Aminoamido minocycline or Dingglyminocycline, which was approved by the FDA in June 2005, is the first glycylcycline antibiotic approved for marketing. The molecular structure is as follows: [0003] [0004] Although tigecycline and minocycline have many similarities in structure, the former is obviously superior to traditional tetracyclines in terms of antibacterial spectrum range and drug-resistant bacteria, and has broad-spectrum antimicrobial activity. Treatment of complicated intra-abdominal infections (cIAI) ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07C237/26C07C231/24
Inventor 邵昌王涛杨志钧袁建勇陈鹏叶伟东罗敏玉戈梅
Owner SHANGHAI LAIYI BIOMEDICAL RES & DEV CENT
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap